People: NuVasive Inc (NUVA.O)

NUVA.O on Nasdaq

46.00USD
6 May 2015
Change (% chg)

$-0.65 (-1.39%)
Prev Close
$46.65
Open
$46.69
Day's High
$46.75
Day's Low
$45.61
Volume
823,952
Avg. Vol
668,655
52-wk High
$51.23
52-wk Low
$31.71

Search Stocks

Summary

Name Age Since Current Position

Gregory Lucier

50 2015 Interim Chief Executive Officer, Chairman of the Board

Patrick Miles

49 2015 President, Chief Operating Officer

Quentin Blackford

35 2014 Chief Financial Officer, Chief Accounting Officer

Jason Hannon

42 2010 Executive Vice President - Corporate Development, General Counsel, Secretary

Matthew Link

39 2013 Executive Vice President - U.S. Sales

Mike Paolucci

54 2014 Executive Vice President - Global Human Resources

Carol Cox

2014 Executive Vice President - Strategy and Corporate Communications

Russell Powers

44 2012 Executive Vice President - International

Jack Blair

71 2001 Independent Director

Peter Farrell

72 2005 Independent Director

Lesley Howe

70 2004 Independent Director

Peter Leddy

50 2011 Independent Director

Eileen More

67 2007 Independent Director

Richard Treharne

63 2009 Independent Director

Tina Jacobsen

IR Contact Officer

Biographies

Name Description

Gregory Lucier

Mr. Gregory T. Lucier is Interim Chief Executive Officer, Chairman of the Board of the Company. He was an Independent Director of the NuVasive Inc. Mr. Lucier has over 20 years of executive management experience and currently serves as Chairman of the Board and Chief Executive Officer of Life Technologies Corporation, a global biotechnology company. Previously, he served as Chief Executive Officer of Invitrogen Corporation from May 2003 until Invitrogen Corporation and Applied Biosystems merged to form Life Technologies in November 2008. Prior to joining Invitrogen Corporation, Mr. Lucier served as Chief Executive Officer and President at GE Medical Systems Information Technologies, Vice President for Global Services at GE Medical Systems and President of GE-Harris Railway Electronics. He currently serves on the board of RainTree Oncology Services, CareFusion, Synthetic Genomics, Rady Children’s Hospital and is board chairman for Sanford-Burnham Medical Research Institute. Mr. Lucier received a Bachelor of Science Degree with high distinction in Industrial Engineering from Pennsylvania State University and a Master of Business Administration degree from Harvard Graduate School of Business Administration.

Patrick Miles

Mr. Patrick W. G. Miles is President, Chief Operating Officer of NuVasive, Inc., effective February 1, 2015. Prior to that, he served as President, Americas from January 2010 to October 2011, as Executive Vice President of Product Marketing and Development from January 2007 to December 2009, as Senior Vice President of Marketing from December 2004 to January 2007, and as Vice President, Marketing from January 2001 to December 2004. Mr. Miles has over 20 years of experience in the orthopaedic industry. Mr. Miles has also served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, as well as serving in several positions with Smith & Nephew plc. Mr. Miles received a B.S. in Finance from Mercer University.

Quentin Blackford

Mr. Quentin Blackford has been appointed as Chief Financial Officer, Chief Accounting Officer of the NuVasive Inc, effective August 1, 2014. Mr. Blackford has served as Executive Vice President of Finance, Accounting and Investor Relations since February 2014, following his tenure as Senior Vice President of Finance & Investor Relations since July 2012, and, prior to that, he served as Vice President, Finance from January 2011. Mr. Blackford joined NuVasive in 2009 as our Corporate Controller and has more than ten years of experience in the healthcare industry, including his time at Zimmer Holdings, Inc. where he held various roles and responsibilities, including the Director of Finance & Controller for Zimmer’s Dental Division where he was responsible for all finance, accounting and IT activities for the worldwide division. Prior to his role at Zimmer’s Dental Division, Mr. Blackford directed the corporate-wide financial planning and analysis function for Zimmer Holdings, Inc. Mr. Blackford is a Certified Public Accountant and obtained Bachelor of Science degrees in both Accounting and Business Administration from Grace College.

Jason Hannon

Mr. Jason M. Hannon is Executive Vice President - Corporate Development, General Counsel and Secretary of NuVasive, Inc., since January 2010. Prior to that, Mr. Hannon served as Senior Vice President of Corporate Development, General Counsel and Secretary from January 2009 to December 2009, as Senior Vice President, General Counsel, and Secretary from January 2007 to December 2008, and as Vice President of Legal Affairs and Secretary from June 2005 to January 2007. Prior to joining NuVasive, Mr. Hannon practiced corporate and transactional law at the law firms of Brobeck Phleger & Harrison LLP and Heller Ehrman LLP, specializing in mergers and acquisitions, public and private financing, joint ventures, licensing arrangements, and corporate governance matters. Mr. Hannon also served as a law clerk to the Honorable Jerome Farris of the U.S. Court of Appeals for the Ninth Circuit. Mr. Hannon received a B.A. degree from the University of California, Berkeley and a J.D. from Stanford Law School.

Matthew Link

Mr. Matthew W. Link is Executive Vice President - U.S. Sales of NuVasive, Inc., since January 2013. Prior to that, Mr. Link served as Senior Vice President of Sales, East from January 2012 to December 2012, as Area Vice President, South from April 2010 to December 2012 and as Sales Director, Atlantic from January 2008 to March 2010. Mr. Link joined NuVasive as Area Business Manager for Virginia and Tennessee in May 2006. Prior to joining NuVasive, Mr. Link worked for DePuy as a sales representative from July 2002 to March 2004 in their orthopaedics division and as a territory manager in their spine division from March 2004 to May 2006. Mr. Link received a B.S. in Education from the University of Virginia.

Mike Paolucci

Mr. Mike Paolucci is the Executive Vice President - Global Human Resources of the NuVasive Inc. Mike Paolucci joins NuVasive from Life Technologies Corporation™, a global life sciences company with over $4 billion in revenue, which was recently acquired by Thermo Fisher Scientific. He brings more than 20 years of broad global human resources experience at the executive and board level that will be instrumental to NuVasive's evolution into a larger, global business. At Life Technologies, Paolucci was responsible for the global compensation and benefit programs that encompassed more than 10,000 employees in nearly 40 countries. He also served as a human resources business partner for various business segments and was responsible for the Company's human resources technology systems. Prior to Life Technologies, he served as Vice President in various human resources capacities at Hewlett-Packard and EDS Corporation, from 2000 to 2009.

Carol Cox

Ms. Carol Cox is Executive Vice President - Strategy and Corporate Communications of the NuVasive Inc. Cox is an executive with extensive global healthcare experience in corporate strategy, investor relations, corporate communications, media relations, brand strategy and government relations. She joins NuVasive from Sanford-Burnham Medical Research Institute (Sanford-Burnham) where she served as senior vice president, External Affairs, leading external and internal communications, philanthropy, marketing, government relations and efforts to elevate the Institute's global recognition. Prior to Sanford- Burnham, she served as senior vice president of External Affairs and Corporate Communications at Life Technologies, where she spearheaded global strategies to drive awareness of the company's major initiatives, enhance its global brand, and maintain its corporate reputation across multiple stakeholder groups. Before joining Life Technologies, Cox was vice president of Investor Relations at CareFusion Corporation and senior vice president for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals. She holds a bachelor's of arts degree in Foreign Affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.

Russell Powers

Mr. Russell A. Powers has been appointed as Executive Vice President - International of NuVasive, Inc., since October 2012. Prior to that, Mr. Powers served as Senior Vice President, Operations from April 2012 to October 2012 and Senior Vice President, Spinal & Biologics from April 2010 through April 2012. Mr. Powers served in various capacities at Medtronic Sofamor Danek during his thirteen years with the company, most recently as Vice President, US Sales Operations from May 2009 to April 2010 and as Vice President, International from May 2003 to April 2009. Mr. Powers began his career in orthopaedics with Smith & Nephew as a member of the Trauma Marketing team. Mr. Powers received a B.B.A. from the University of Memphis.

Jack Blair

Mr. Jack R. Blair is an Independent Director of NuVasive, Inc., since August 2001. During his 18 year career with Smith & Nephew plc ending in 1998, Mr. Blair served in various capacities with Smith & Nephew plc and Richards Medical Company, which was acquired by Smith & Nephew in 1986, most recently as group president of its North and South America and Japan operations. He held the position of President of Richards Medical Company. Until November 2007, when the company was sold, Mr. Blair served as chairman of the board of directors of DJO, Inc., an orthopaedic medical device company. He also serves as a director of a privately-held orthopaedic company and a privately-held specialty chemicals company. Mr. Blair holds a B.A. in Government from Miami University and an M.B.A. from the University of California, Los Angeles.

Peter Farrell

Dr. Peter C. Farrell, Ph.D., is an Independent Director of NuVasive, Inc., since January 2005. Dr. Farrell is founding Chairman of ResMed, Inc. a developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing, and was its Chief Executive Officer from 1989 to 2007 and again from February 2011 until March 2013. Dr. Farrell serves as a director of California Healthcare Institute. Dr. Farrell holds bachelor and masters degrees in chemical engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in bioengineering from the University of Washington, Seattle and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.

Lesley Howe

Mr. Lesley H. Howe is an Independent Director of NuVasive, Inc., since February 2004. Mr. Howe has over 40 years of experience in accounting, finance and business management within a variety of industries. From December 2001 to May 2007, he served as Chief Executive Officer of Consumer Networks LLC, a San Diego-based Internet marketing and promotions company. Mr. Howe had a 30 year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, in which he was an audit partner for 23 years and an area managing partner/managing partner of the Los Angeles office of KPMG for three years. Mr. Howe currently serves on the board of directors of Jamba, Inc., the retailer of quality blended fruit beverages; and Volcano Corporation, a developer of products that aid in the diagnosis and treatment of vascular and structural heart disease. He previously served on the board and was chair of the Audit Committee of DJ Orthopedics Inc. from 2002 through 2008. Mr. Howe received a B.S. in business administration from the University of Arkansas.

Peter Leddy

Dr. Peter Michael Leddy, Ph.D., is an Independent Director of NuVasive, Inc., since July 28, 2011. Since 2005, Dr. Leddy has served as Senior Vice President of Global Human Resources at Life Technologies, a biotechnology company. From 2000 to 2005, Dr. Leddy held several senior management positions with Dell Incorporated, where he was responsible for global talent and human resources in the Americas, overseeing 7,500 employees. From 1999 to 2000, Dr. Leddy served as the Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites), and from 1989 to 1999, he held a variety of executive and human resource positions at PepsiCo, Inc. Dr. Leddy received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. degrees in industrial/organizational psychology from the Illinois Institute of Technology.

Eileen More

Ms. Eileen M. More is an Independent Director of NuVasive, Inc., since June 2007. Ms. More was a General Partner at Oak Investments, one of the venture capital funds in the United States, for over 20 years. Ms. More founded Oak Partner’s healthcare investment practice, and was also an active investor in information technology, with early stage investments in dozens of healthcare and technology companies. Her investments include leadership roles with Genzyme Corporation, Alexion Pharmaceuticals, OraPharma, Inc., Osteotech, Inc. and Compaq Computer. Ms. More retired from Oak in 2002. She currently serves on the board of directors of Optherion, Inc., a privately held company. She formerly served on the board of directors of KBL Healthcare Acquisition Corp. III, a publicly owned blank check corporation. Ms. More was formerly the Chairman Emeritus of the Connecticut Venture Group and a board member of the University of Connecticut Research and Development Corporation. Ms. More attended the University of Bridgeport and has been awarded a Chartered Financial Analyst (CFA) charter.

Richard Treharne

Dr. Richard W. Treharne, Ph.D., is an Independent Director of NuVasive, Inc., since August 2009. Dr. Treharne has over 30 years of experience in the orthopaedic industry with over 15 years in senior management. From August 2006 to the present, Dr. Treharne has held the position of Vice President, Orthopaedic Research at Active Implants Corporation, a privately held orthopaedic company focused on innovative technologies for degenerative conditions of the joints. During his sixteen years at Medtronic Sofamor Danek, from November 1990 to August 2006, he served as a Group Director — Regulatory and Clinical Affairs for three months and then various Vice President positions for the remainder of his tenure, most recently as Vice President — Regulatory Affairs. He also held several director level positions at Smith & Nephew plc prior to working at Medtronic. Dr. Treharne holds an M.B.A. from the University of Memphis, a Ph.D. and a M.S.E. from The University of Pennsylvania, and a B.S. in Metallurgical Engineering from The Ohio State University.

Tina Jacobsen

Basic Compensation

Options Compensation

Search Stocks